Mutations in the RS1 gene that encodes the discoidin domain containing retinoschisin cause X-linked juvenile retinoschisis (XLRS), a common macular degeneration in males. Disorganization of retinal layers and electroretinogram abnormalities are hallmarks of the disease and are also found in mice deficient for the orthologous murine protein, indicating that retinoschisin is important for the maintenance of retinal cell integrity. Upon secretion, retinoschisin associates with plasma membranes of photoreceptor and bipolar cells, although the components by which the protein is linked to membranes in vivo are still unclear. Here, we show that retinoschisin fails to bind to phospholipids or unilamellar lipid vesicles. A recent proteomic approach identified the Na/K-ATPase subunits ATP1A3 and ATP1B2 as binding partners of retinoschisin. We analyzed mice deficient for retinoschisin (Rs1h 2/Y ) and ATP1B2 (Atp1b2 2/2 ) to characterize the role of Na/K-ATPase interaction in the organization of retinoschisin on cellular membranes. We demonstrate that both the Na/K-ATPase and retinoschisin are significantly reduced in Atp1b2 2/2 retinas, suggesting that retinoschisin membrane association is severely impaired in the absence of ATP1A3 and ATP1B2 subunits. Conversely, the presence of ATP1A3 and ATP1B2 are obligatory for binding of exogenously applied retinoschisin to crude membranes. Also, co-expression of ATP1A3 and ATP1B2 is required for retinoschisin binding to intact Hek293 cells. Taken together, our data support a predominant role of Na/K-ATPase in anchoring retinoschisin to retinal cell surfaces. Furthermore, altered localization of ATP1A3 and ATP1B2 is a notable consequence of retinoschisin deficiency and thus may be an important downstream aspect of cellular pathology in XLRS.
INTRODUCTION
X-linked juvenile retinoschisis (XLRS, OMIM 312700) is a common form of juvenile macular degeneration in males (1, 2) . The early stage of the disease is typically characterized by bilateral foveal schisis which occurs at various levels of the retina especially at the inner nuclear layer (INL) (3) . The pathologic features of XLRS include defects in visual signal transmission which lead to a decrease of the b-wave amplitude with preservation of the a-wave in the scotopic electroretinogram (the so-called 'negative ERG') (4). Visual function is often stable until patients reach middle age, although serious complications such as vitreous hemorrhage and retinal detachment can lead to severe visual impairment even in young children (1) .
A positional candidate gene approach identified RS1 on Xp22.1 as the causative gene associated with XLRS (5) . RS1 consists of six exons and is specifically expressed in the retina (5) and the pineal gland (6) . It encodes 224 amino acids containing an N-terminal 23 amino acid secretory signal and a highly conserved discoidin domain which comprises over 75% of the processed protein. The 24 kDa retinoschisin polypeptide is secreted as a disulfide-linked homo-oligomeric complex (7) and distributes along the surface membranes of rod and cone photoreceptors as well as bipolar cells (8) .
To date, over 160 unique sequence variants of the RS1 gene have been associated with the disease (http://www.dmd.nl/rs/). Of these, the majority represent missense mutations in the discoidin domain that cause protein misfolding and retention in the endoplasmic reticulum (ER) (9, 10) . Mutations in the leader sequence affect retinoschisin biosynthesis by altering either post-transcriptional pre-mRNA splicing, translation initiation or secretion (9, 11) . In addition, several deletions, insertions, duplications and splice-site mutations predicted to cause truncated proteins have been found in XLRS patients. Mutant peptides incapable of secretion undergo ER-associated degradation leading to RS1 null phenotypes (9) . Another set of mutations causing the substitution of cysteine residues critical for disulfide-mediated octamer formation results in the release of mutant proteins that fail to assemble in the biologically active conformation (7) .
To study XLRS pathology, we and others have generated mice with a targeted disruption of the murine ortholog of RS1, termed Rs1h (12,13). Mice lacking retinoschisin display several characteristics typical for the human XLRS phenotype. This includes pathognomonic schisis cavities in the INL and a highly disorganized outer nuclear layer (ONL). Also, a negative ERG is found in Rs1h knockout mice (Rs1h 2/Y ), followed by progressive photoreceptor degeneration (12) (13) (14) . This suggests that retinoschisin is essential for maintaining the structural integrity of the retinal cell layers and of the synaptic connections between photoreceptors and second-order neurons.
Other proteins containing discoidin domains including coagulation factors V and VIII, discoidin domain receptors and milk fat globule proteins play a role in cell adhesion, signaling, developmental processes, proliferation and remodeling (15) . Discoidin domains interact with a variety of molecules such as growth factors, phospholipids and neutral lipids, galactose with its derivatives and collagens (16) . Although specific binding partners have been identified for individual discoidin motifs, most of these appear to have a predominant role in membrane anchoring.
The molecular mechanism by which retinoschisin associates with retinal membranes is poorly understood and remains controversial. Protein-lipid overlay assays and atomic force microscopy indicated direct binding of retinoschisin to anionic phosphatidylserine-containing phospholipids in the presence of calcium (17, 18) . In an independent approach, native homo-octameric retinoschisin failed to bind immobilized phospholipids or lipid vesicles reconstituted from synthetic phospholipids or retinal lipids (19) . The latter study also provided evidence for physical interaction of retinoschisin with a Na/K-ATPase -SARM1 complex (19) . Immunoprecipitation of retinoschisin with a specific antibody co-purified the a3 (ATP1A3) and b2 (ATP1B2) subunits of the Na/K-ATPase and SARM1, a sterile alpha and Toll/IL-1R resistance motif containing intracellular protein (19) . Moreover, ATP1A3 and SARM1 were shown to co-localize with retinoschisin in photoreceptor and bipolar cells of mouse retina (19) .
The Na/K-ATPase is an essential enzyme which generates the transmembrane Na + and K + gradients required to maintain cellular homeostasis (20) . It is composed of equimolar amounts of a and b subunits forming heterodimers that are integrated into the plasma membrane (21) . The a subunit contains the catalytic site for ATP hydrolysis, and the b subunit is a glycoprotein that is implicated in maturation and membrane targeting of the enzyme. Tissuespecific regulatory g subunits have also been shown to associate with the Na/K-ATPase (22) . The different retinal cell types express unique combinations of a and b subunits, with the ATP1A3 and ATP1B2 subunits being highly abundant in photoreceptor and bipolar cells (23) . Interestingly, the ATP1B2 subunit was initially described as an adhesion molecule on glial cells that mediates neuron -astrocyte interaction and neuron migration indicating important non-enzymatic roles for ATP1B2 (24, 25) .
The aim of this study was to further analyze retinoschisin binding to retinal membranes. Similar to the data published by Molday et al. (19) , we failed to observe an interaction of retinoschisin with phospholipids. Instead, we present novel data from molecular biological, biochemical and immunohistochemical experiments that support a predominant role of the Na/K-ATPase subunits ATP1A3 and ATP1B2 in anchoring retinoschisin to cellular surfaces in vivo.
RESULTS

Binding of retinoschisin to phospholipids
To follow-up on previous studies reporting ambiguous results (17) (18) (19) , we tested the ability of retinoschisin to bind phospholipids immobilized on tissue culture plastic. Enzyme-linked immunosorbent assay (ELISA)-based detection of bound proteins demonstrated no binding of retinoschisin to either 3-sn-phosphatidyl-L-serine (PS), 3-sn-phosphatidylethanolamine (PE), L-a-phosphatidylcholine (PC) or a lipid mixture of 60% PC, 35% PE and 5% PS (Fig. 1A) . As a positive control, MFGE8 that contains two discoidin-type domains specifically bound immobilized PS (Fig. 1A ) consistent with its reported selective affinity for PS (26) . The failure of MFGE8 to bind the immobilized lipid mixture may be explained by an insufficient PS content in the lipid mixture or the known preference of MFGE8 for highly curved membranes (26) .
To analyze whether retinoschisin and MFGE8 bind phospholipids organized in vesicles with curved membranes, we prepared unilamellar vesicles of different lipid composition and incubated them with both ligands. Western blot analysis of vesicle-bound proteins detected MFGE8 in all vesicle fractions containing PS, whereas retinoschisin failed to bind to any composition of phospholipid vesicles (Fig. 1B) . Thus, in agreement with earlier findings which have not supported specific binding of endogenous retinoschisin from retina or retinoblastoma cells to synthetic phospholipids or retinal membrane lipids (19) , our data strongly argue against retinoschisin binding to phospholipids.
Expression of ATP1A3, ATP1B2 and SARM1 in retinoschisin-deficient mice
Retinoschisin has been shown to associate with Na/K-ATPase subunits ATP1A3, ATP1B2 and SARM1 (19) . To investigate the effect of retinoschisin deficiency on gene expression of murine Atp1a3 and Atp1b2, we performed semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) with RNAs isolated from various Rs1h 2/Y tissues. Consistent with other reports of Atp1a3 and Atp1b2 tissue distribution (27) , Atp1a3 mRNA was predominantly expressed in neuronal tissues (brain and retina), whereas specific Atp1b2 transcripts were detected in all tissues analyzed including the heart, lung, kidney, liver, muscle, brain and retina ( Fig. 2A) . The pattern of Atp1a3 and Atp1b2 mRNA expression was similar in wild-type (wt) and retinoschisin-deficient mice ( Fig. 2A) . The weak amplification of Atp1a3 in lung tissues of Rs1h
2/Y
but not wt is likely due to stochastic processes in RT-PCR amplification of rare transcripts and was also observed in lung RNA from Atp1b2 2/2 mice. In the RT-PCR amplification product of Atp1b2 from retinal mRNA of both wt and Rs1h 2/Y , we noted a tissue-specific 347 bp product in addition to the expected 299 bp fragment present in all other tissues tested ( Fig. 2A) . Sequencing of the two fragments revealed that the 299 bp product represents the coding sequence of Atp1b2 as referenced in sequence NM_001678. The larger fragment contains 48 additional nucleotides which represent two novel in-frame exons (5a and 5b) with conserved donor and acceptor splice sites within intron 5 of the Atp1b2 gene (Supplementary Material, Fig. S1A ). Several mouse expressed sequenced tags (e.g. BQ951712) have been isolated from retinal cDNA libraries which also encompass exons 5a and 5b. This novel sequence encodes an additional 16 amino acids (aa) in the extracellular domain of ATP1B2 (Supplementary Material, Fig. S1B and C) and is highly conserved between mice and humans sharing 75% amino acid identity. Taken together, our findings suggest the presence of a retina-specific isoform of ATP1B2 which we termed ATP1B2iso.
We next analyzed ATP1A3, ATP1B2 and SARM1 protein expression by western blotting. At postnatal day 10 (P10), ATP1A3 and ATP1B2 were detected in total retinal and brain extracts from both wt and retinoschisin-deficient mice (Fig. 2B ). ATP1B2 protein was not detected in other tissues expressing the Atp1b2 mRNA, possibly due to ER retention and rapid degradation of unassembled ATP1B2 subunits (28) . The ubiquitously expressed SARM1 protein was present in all tissues analyzed from both wt and Rs1h (Fig. 2B ). Of note, the SARM1 antibody similarly labeled multiple protein species in retinal extracts from control and mutant mice (Fig. 2B) . A number of bands detected by SARM1 antibodies in the retina were also reported by Molday et al. (19) , although the nature of this labeling is currently unknown.
Binding of recombinant retinoschisin to membranes from murine retina and brain
Membranes from different organs have distinct compositions that are often related to their function. To investigate the dependence of retinoschisin membrane association on a specific lipid or protein content, we performed binding assays using crude membranes prepared from retinoschisindeficient tissues at P10. Western blot analysis repeatedly showed that recombinant retinoschisin tightly binds to membranes from retina and total brain tissue even after several washes with phosphate-buffered saline (PBS) but not to membranes isolated from the lung, spleen, heart, muscle, kidney and liver (Fig. 3) . Weak signals from non-specific binding of retinoschisin were occasionally observed in the membrane fraction (P1) from non-neuronal tissues (e.g. heart; Fig. 3 ), but were easily removed after a second washing step with PBS. Having shown that ATP1A3 and ATP1B2 proteins are expressed in the retina and brain from 10-day-old Rs1h 2/Y mice ( Fig. 2B ), these data corroborate that retinoschisin associates with membranes in the presence of ATP1A3 and ATP1B2.
Retinoschisin expression and localization in ATP1B2-deficient mice ATP1B2-deficient mice were used to further study the interaction of retinoschisin with the Na/K-ATPase. Although Vesicles prepared from different lipid components were incubated with retinoschisin or MFGE8 (T, total). After centrifugation, aliquots from supernatant (S) and lipid-bound protein-containing pellet (P) were analyzed by western blotting using anti-retinoschisin or anti-Rho (1D4) antibodies to detect bound retinoschisin and MFGE8, respectively. phenotypically normal at birth, Atp1b2 2/2 mice display motor coordination deficits and paralysis during their third postnatal week and die around 17-18 days after birth (29) . The retinas of Atp1b2 null mutants develop normally, but photoreceptor cells undergo increasing apoptotic cell death from P9 onward when compared with wt animals (30) . RT-PCR analysis showed that the gene expression of Rs1h and Atp1a3 in P10 mice lacking ATP1B2 was similar to that of wt mice, with Rs1h being expressed in the retina and Atp1a3 in the brain and retina (Fig. 4A ). However, western blot analysis of total proteins, crude membrane and cytosol fractions from retinal tissues of control animals and mice carrying heterozygous or homozygous Atp1b2 null alleles revealed a complete loss of ATP1A3 protein from ATP1B2-deficient retina (Fig. 4B) . Furthermore, retinoschisin protein was absent from crude retinal membranes of Atp1b2 2/2 mice and significantly reduced in the total protein extract and cytosol fraction (Fig. 4B ). In contrast, SARM1 protein levels were unaffected in Atp1b2 2/2 retinas (Fig. 4B) .
Immunofluorescence microscopy was then used to visualize the distribution of ATP1A3, retinoschisin and SARM1 in cryosections of wt and Atp1b2 2/2 retinas at P14. Immunolabeling of wt sections revealed a remarkable overlap of ATP1B2, ATP1A3 and retinoschisin localization in the photoreceptor inner segments, outer plexiform layer (OPL), bipolar cells of the INL and the inner plexiform layer (IPL) (Fig. 4C , upper panel). The immunostaining produced by anti-SARM1 antibodies appeared different from that of ATP1B2, ATP1A3 and retinoschisin and coincides with a wider distribution in the retinal layers as reported earlier (19) . Similar to ATP1B2, ATP1A3 and retinoschisin, SARM1 was found in the photoreceptor inner segments, the OPL and IPL, but it was also observed in numerous cell bodies in the INL as well as ganglion cells (Fig. 4C, upper panel) .
Confirming the results from western blotting retinal extracts of ATP1B2-deficient mice (Fig. 4B ), ATP1B2 and ATP1A3 immunoreactivity was absent in Atp1b2 2/2 retinal cryosections, whereas SARM1 protein distribution was not altered in Atp1b2 2/2 retinas when compared with wt ( Fig. 4C , lower panel). High-resolution confocal laser scanning microscopy of wt, retinoschisin-and ATP1B2-deficient retinas revealed residual retinoschisin immunoreactivity in Atp1b2 2/2 -derived sections at the level of the OPL and inner segments at P10 (Fig. 4D) supporting the western blot 2/Y tissues at P10 were washed (W) and were then incubated with retinoschisin secreted from cells transiently transfected with an RS1 expression construct (I, input). After several washing and centrifugation steps, aliquots from pellets containing membranes (P1-P4) and supernatants containing unbound proteins (U1-U4) were subjected to western blot analysis using antibodies against retinoschisin. After stripping and reprobing with anti-ATP1B2 antibodies, immunoblots revealed ATP1B2 protein in the membrane fractions (M, P1-P4) from retina and brain (data not shown). results with a strongly reduced retinoschisin expression in retinal extracts from these mice (Fig. 4B ). RS1 immunostaining was absent in Atp1b2 2/2 retinal sections at P14 (Fig. 4C , lower panel and D); the diffuse staining at the level of the photoreceptor inner segments generated by retinoschisin antibodies were similar in Atp1b2 2/2 and Rs1h 2/Y retinas indicating minor unspecific labeling of these structures (Fig. 4D) .
Histological examination of retinal sections from Atp1b2 2/2 mice at P17/P18 (n ¼ 5) showed a reduction in the number of photoreceptor nuclei in the mutants (data not shown) confirming earlier reports of massive photoreceptor degeneration in Atp1b2 2/2 mice at P16 (30) . Schisis-like gaps in the INL were not observed in any of the Atp1b2 2/2 retinas.
Retinoschisin membrane association in ATP1B2-deficient mice
Crude retinal membrane preparations from 10-day-old doubleknockout mice lacking retinoschisin and ATP1B2 were investigated for binding capacity of exogenous recombinant retinoschisin in membrane binding assays similar to those depicted in Fig. 3 . Retinoschisin is present in crude membranes from retinoschisin-deficient Atp1b2 +/2 mice even after three or more consecutive washes with PBS (Fig. 5) . In contrast, the association of recombinant retinoschisin with crude membranes from Rs1h
2/2 retinas was significantly weaker as demonstrated by the failure to detect the retinoschisin protein in the membrane fraction after a single PBS washing step (Fig. 5) . Taken together, these results suggest that retinoschisin membrane association in the retina is severely impaired in the absence of ATP1A3 and ATP1B2.
Retinoschisin membrane association in Hek293-EBNA cells heterologously expressing ATP1A3 and ATP1B2
Mammalian expression systems have been used to express exogenous Na/K-ATPase subunits mainly to assess trafficking and molecular interaction with each other (28) . Here, we overexpressed ATP1A3, ATP1B2 and the retina-specific ATP1B2 isoform ATP1B2iso in Hek293-EBNA cells to assess binding 2/Y and Atp1b2 2/2 mice at P10 and P14 labelled with monoclonal antibodies against retinoschisin. Arrows point to non-specific fluorescence on blood vessels due to the secondary antibody; IS, inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.
of exogenous retinoschisin to the plasma membrane. Nontransfected Hek293-EBNA cells lacking endogenous retinoschisin, ATP1A3 and ATP1B2 expression and cells transfected with ATP1A3, ATP1B2 or ATP1B2iso alone failed to bind recombinant retinoschisin from cell culture medium (Fig. 6 ). In contrast, retinoschisin efficiently bound to Hek293-EBNA cells transfected with both Na/K-ATPase subunits, namely ATP1A3 in combination with either ATP1B2 or ATP1B2iso (Fig. 6) .
Localization of ATP1A3, ATP1B2 and SARM1 in the developing retina of retinoschisin-deficient mice
The onset and severity of the retinal phenotype in the Rs1h Fig. S2A ). The protein content of the synaptic photoreceptor protein MPP4 and the outer segment protein PHRP2 were similar in wt and mutant retina, indicating no or only minimal photoreceptor degeneration in the retinoschisin-deficient mouse at these stages (Supplementary Material, Fig. S2A ). Immunofluorescence microscopy was then performed to visualize the localization of ATP1A3, ATP1B2 and SARM1 proteins around the time of disease onset. In the wt retina, the distribution of retinoschisin, ATP1A3 and ATP1B2 during retinal maturation closely resemble each other and is characterized by increasing labeling of the developing inner segments, synaptic contacts in the OPL and IPL and bipolar cells in the outer zone of the INL from P10 to P18 (Fig. 7A -E) . In contrast, staining intensity of photoreceptor cell bodies declined over time. Retinal cryosections from Rs1h 2/Y eyes at P10 (Fig. 7A) and P12 (Fig. 7B ) labeled with antibodies against ATP1A3 and ATP1B2 showed a similar staining pattern when compared with controls. At P14 (Fig. 7C) , ATP1A3-and ATP1B2-associated immunoreactivity in the inner segments was less intensely accompanied by a brighter labeling of photoreceptor cell bodies in the retinoschisin knockout retina. Immunolabeling of P16 (Fig. 7D) , P18 (Fig. 7E) and Rs1h 2/Y retinas with anti-ATP1A3 and ATP1B2 antibodies exhibited a uniform staining pattern across the retinal layers. More precisely, ATP1A3 and ATP1B2 immunoreactivity was reduced in the inner segments of photoreceptors and increased in the ONL (Fig. 7D, lower  panel) . ATP1A3 and ATP1B2 labeling in the IPL was normal even in areas where the outer retinal layers were markedly disorganized (P18, Fig. 7E ). From P10 to P18, the distribution of SARM1 protein in the inner segments, OPL, INL, IPL and GCL was similar in wt and retinoschisin knockout retina ( Fig. 7A -E) .
DISCUSSION
The exact function of retinoschisin in maintaining the structural integrity of the retina and the related molecular pathways that lead to XLRS pathology are largely unknown. Therefore, identification of potential binding partners and mechanism which enable retinoschisin to interact with the cellular surfaces in the retina are of utmost importance. Our data provide compelling evidence that both Na/K-ATPase subunits ATP1B2 and ATP1A3 are directly involved in anchoring retinoschisin to retinal membranes. Binding assays with crude membranes from Rs1h 2/Y and Rs1h
2/Y
/Atp1b2 2/2 doubleknockout mice indicate that retinoschisin membrane association is implicitly dependent on the presence of the Na/ K-ATPase subunits. This is corroborated by heterologous expression experiments where retinoschisin only binds to Hek293-EBNA cells when both ATP1A3 and ATP1B2 subunits were co-expressed. Finally, we demonstrate a significant loss of retinoschisin in vivo in the Atp1b2 2/2 retina lacking ATP1A3 and ATP1B2 protein expression. 2/Y mice at P10 were washed (W) and then incubated with retinoschisin secreted from cells transiently transfected with an RS1 expression construct (input, I). After several washing and centrifugation steps, aliquots from pellets containing membranes (P1-P4) and supernatants containing unbound proteins (U1-U4) were subjected to western blot analysis using antibodies against retinoschisin. Figure 6 . Exogenous retinoschisin binds to Hek293-EBNA cells heterologously co-expressing ATP1A3 and ATP1B2. Hek293-EBNA cells were transfected with expression constructs for ATP1A3, ATP1B2 and the retina-specific ATP1B2 isoform ATP1B2iso as indicated above and incubated with cell culture medium containing exogenous retinoschisin (input). Cells were intensively washed and denatured with SDS loading buffer prior to western blot analysis using ATP1A3, ATP1B2 and retinoschisin antibodies. The HSP90 immunoblot served as a loading control.
The ATP1A3 subunit is a multispan membrane protein that is responsible for catalytic and transport properties of the Na/ K-ATPase, whereas ATP1B2 acts as a chaperone that facilitates maturation of the enzyme (25) . ATP1B2 also mediates Ca 2+ -independent neuron -astrocyte interaction (25) and regulates neuronal migration, neurite outgrowth and cell size (31, 32) . Retinoschisin has been shown to bind to carbohydrates coupled to agarose with a high preference for galactose (33) . As the large extracellular domain of ATP1B2 contains several glycosylation sites, we speculate that retinoschisin may bind to distinct glycosylated regions of the ATP1B2 ectodomain. Related to this, N-glycosylation of the b1 subunit (ATP1B1) is important for cell -cell adhesion (34) . Moreover, the tightness of intercellular junctions and cell motility correlate with the extent of N-glycan branching of the ATP1B1 subunit without affecting the activity of the pump (35) . N-glycans are essential for normal folding and maturation of ATP1B2 (36) , but the role of glycosylation in the ion-pump-independent functions of ATP1B2 is not known.
Our data show that retinoschisin requires both ATP1A3 and ATP1B2 subunits for anchoring to retinal membranes. However, our experiments could not discriminate which subunit directly interacts with RS1. The major limitation was the finding that ATP1B2 deficiency also leads to a loss of ATP1A3 protein in the retina despite normal ATP1A3 mRNA levels. We assume that pre-assembly of ATP1B2 and ATP1A3 subunits is required for the transition of the ATP1A3 subunit from the ER to the plasma membrane. This finding is in consistent with the observation that the Na/ K-ATPase a subunit is unable to exit the ER unless it is assembled with a b subunit in various expression systems (37) . Conversely, the association of the ATP1B2 subunit with an a subunit is also required for its export from the ER (28) . This reciprocal interaction indicates that ATP1B2 can regulate its different molecular activities only as a component of the mature Na/K-ATPase heterodimer (28) . In agreement with this, we show that the expression of both subunits, ATP1A3 and ATP1B2, were necessary for efficient binding of recombinant retinoschisin to intact cells.
We demonstrated that the decreased retinoschisin protein content in the Atp1b2 2/2 retina is not caused by decreased mRNA levels and thus may be attributable to either a reduced translation rate or increased turnover of retinoschisin in the absence of the Na/K-ATPase. Whether the Na/ K-ATPase may be important for retinoschisin trafficking and/or stabilization or other phenomena remains to be resolved.
Here, we have also identified a novel retina-specific splice variant of the ATP1B2 subunit (ATP1B2iso). When co-expressed with ATP1A3, ATP1B2iso conferred retinoschisin binding capacity to Hek293-EBNA cells similar to the regular ATP1B2 isoform. The additional 16 amino acids in the extracellular portion of ATP1B2iso lack putative Nglycosylation sites but likely change the structure of the ectodomain, thereby influencing the association of ATP1B2 with retinoschisin and other proteins. A further in-depth investigation into the role of ATP1B2iso in retinal function and possibly XLRS pathology is needed.
The identification of the cytoplasmic adaptor protein SARM1 as a component of the retinoschisin-Na/K-ATPase complex led to the suggestion that retinoschisin binding to Na/K-ATPase may trigger retinal signaling pathways via SARM1 and possibly other upstream or downstream signaling molecules (19) . Interestingly, SARM1 plays a role in innate immunity (38) , which is a main constituent in the pathogenesis of the genetically complex age-related macular degeneration (39) (40) (41) (42) . SARM1 (alias MyD88-5) is also expressed in neurons, where it associates with mitochondria, microtubules and JNK3 to regulate cell death during deprivation of oxygen and glucose (43) . Here we show that SARM1 protein levels and its distribution in the mouse retina were not influenced by the lack of retinoschisin or the Na/K-ATPase ATP1A3 and ATP1B2 subunits. This, however, cannot exclude that intracellular pathways may be linked to the Na/K-ATPase complex in the retina. Likewise, expression of ATP1B2 in ATP1B2-deficient cells results in a dramatic increase in cell size through selective activation of the Akt/mTOR/S6K signaling pathway (32) . Therefore, further investigation into the role of SARM1 and other signaling pathways in retinoschisin-and ATP1B2-related retinal phenotypes is warranted.
Disruption of the retinoschisin -Na/K-ATPase interaction in Rs1h 2/Y mice caused significant reduction in ATP1A3 and ATP1B2 expression in the photoreceptor inner segments and a mislocalization of ATP1A3 and ATP1B2 in the outer retina at the time of eye opening in mouse development. This indicates a direct stabilizing effect of retinoschisin on the Na/K-ATPase complex. Thus, insufficient Na/K-ATPase activity may contribute to the progressive photoreceptor cell death observed in retinoschisin knockout mice. In addition, loss of Na/K-ATPase from the plasma membrane could impair ATP1B2-mediated intercellular adhesion and intracellular signaling, leading to destabilization of the retinal structure. Taken together, our studies strongly support previous findings which have shown a direct interaction between retinoschisin and Na/K-ATPase (19) . In addition, we provide the first in vivo evidence that the retinal Na/K-ATPase mediates the anchoring of retinoschisin to retinal plasma membranes. The dramatic decrease of retinoschisin in ATP1B2-deficient retinas and its reduced binding capability to retinal membranes from these animals argues against an essential contribution of retinoschisin -lipid interactions in vivo as suggested previously (17, 18) . In fact, our data indicate that Na/K-ATPase binding is necessary and sufficient to establish the proper localization of retinoschisin in the retina. Importantly, as RS1 mutations often lead to deficiency of retinoschisin in XLRS patients, XLRS pathology may involve secondary features due to difficulties in membrane targeting of the Na/ K-ATPase. This may provide a deeper understanding of the cellular pathology in XLRS and possibly could broaden our approach to therapeutic treatment options.
MATERIAL AND METHODS
Animal models
The Rs1h 2/Y mouse was generated as described earlier (12) , whereas the Atp1b2 2/2 mouse (29) (EM00023) was obtained from the European Mouse Mutant Archive (Munich, Germany). Both mouse lines were maintained on a C57BL/6 background. To obtain retinoschisin/ATP1B2 doubleknockout mice, Rs1h 2/2 females were first bred with Atp1b2 +/2 males. Male offspring that carried the Rs1h null allele and were heterozygous for the Atp1b2 null allele (Rs1h 2/Y /Atp1b2 +/2 ) were then interbred with heterozygous females (Rs1h +/2 /Atp1b2 +/2 ) to generate double-knockout animals of both gender. Mice were housed under specific pathogen-free barrier conditions at the Central Animal Facility of the University of Regensburg and maintained under conditions established by the institution for their use, in strict compliance with NIH guidelines. Mice were sacrificed by cervical dislocation after inhalation of carbon dioxide or by decapitation when younger than 14 days after birth. Animals were dissected and the organs were immediately processed or stored at 2808C.
Primary antibodies
Rabbit polyclonal antibodies against retinoschisin were described previously (8) . Mouse monoclonal anti-retinoschisin (RS1-3R10) and anti-rhodopsin (Rho-1D4) antibodies were kindly provided by R.S. Molday (University of British Columbia, Vancouver, Canada). Rat monoclonal antibodies against ATP1B2 (426) were described earlier (30) . Mouse monoclonal anti-ATP1A3 and rabbit polyclonal anti-SARM1 were purchased from Abcam (Cambridge, UK), mouse monoclonal anti-ATP1B2 was from BD Biosciences (San Jose, CA, USA), mouse monoclonal anti-b-actin and mouse monoclonal anti-ACTB were from Sigma-Aldrich (St Louis, MO, USA) and mouse monoclonal anti-HSP90 was from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Protein extracts from tissue, sodium dodecyl sulfatepolyacrylamide gel electrophoresis and western blot analysis Mouse tissues were homogenized in 200 ml of extraction buffer (0.5 mM CHAPS, 10 mM HEPES, pH 7.4, 1 mM MgCl 2 , 1 mM CaCl 2 , 100 mM NaCl, 0.2% Triton X-100, 4.5% glycerol and 1 mM PMSF) using a TissueLyzer (QIAGEN, Hilden, Germany) and further mixed by rotation for 1 h at room temperature (RT). The extracts were centrifuged for 5 min at 5000g to remove cell debris. Protein concentrations were determined by Bradford assay (Roti-quant w ; Roth, Karlsruhe, Germany). Sodium dodecyl sulfate (SDS) sample buffer was added and the proteins were separated by sodium dodecyl sulfate -polyacrylamide gel electrophoresis on 10% gels. For western blotting, proteins were electrophoretically transferred onto polyvinylidine difluoride membranes (Millipore, Bedford, MA, USA). After blocking in PBS containing 3.5% nonfat dry milk, the membranes were labeled with the primary antibody for 1 h at RT followed by goat anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase (Calbiochem, San Diego, CA, USA). Western blots were visualized with SuperSignal West PICO Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA). Densitometry was performed with Total lab TL100 software (Nonlinear Dynamics, Durham, NC, USA).
Reverse transcriptase-polymerase chain reaction
Total RNA was extracted from frozen tissues by RNeasy Mini Kit (QIAGEN). The cDNA synthesis was performed with 1.5 mg of RNA using the AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's recommendation. Primer sequences and PCR conditions for amplification of Atp1a3, Atp1b2, Rs1h and the housekeeping gene Sdha are summarized in Supplementary Material, Table S1 .
Cloning and transfection
The full-length cDNAs of human RS1, human milk fat globule-EGF factor 8 (MFGE8), ATP1A3 and ATP1B2 were amplified from human retinal or liver RNA by RT-PCR and cloned into the pCEP4 vector (Invitrogen, Carlsbad, CA, USA). MFGE8 was cloned in-frame with a C-terminal rhodopsin (Rho)-1D4 tag (TETSQVAPA). All clones were sequence verified by Sanger sequencing of plasmid DNA. Hek293-EBNA cells (Invitrogen) were transfected with the expression constructs using TransIT w -LT1 transfection reagent (Mirus Bio LLC, Madison, WI, USA).
Preparation of ligands
When cells transfected with RS1 or MFGE8 grew confluent, they were kept in fetal calf serum (FCS)-free medium for 2 days. Cell culture medium was harvested and the protein levels of retinoschisin and MFGE8 were analyzed by western blotting. In addition, the concentration of retinoschisin in the cell culture medium was determined by ELISA. Briefly, full-length recombinant retinoschisin with a C-terminal His5 tag was expressed and purified from bacteria. Recombinant protein and cell culture medium with and without retinoschisin was adsorbed in 96-well microtiter plates overnight at 48C. After washing with PBS, the plate was blocked with 3% milk/0.05% Tween 20 in PBS and incubated with rabbit polyclonal anti-RS1 antibody 1:1000 and secondary goat antirabbit IgG peroxidase conjugated for 1 h each. The antigenantibody complexes were detected using 3,3 ′ ,5,5 ′ -tetramethylbenzidine (TMB) as a substrate and the optical density was read at 450 nm. The concentration of secreted retinoschisin in cell culture medium was calculated to be 14 mg/ml.
Binding to immobilized phospholipids
The binding to phospholipids immobilized onto 96-well MaxiSorp Microtiter Plates (Nunc, Rochester, NY, USA) was tested as described by Andersen et al. (44) with minor modifications. Briefly, PS, PE (both from bovine brain), PC and a lipid mixture (60% PC, 35% PE and 5% PS) both isolated from egg yolk (all from Sigma-Aldrich) were each dissolved in methanol/chloroform (2:1) at a concentration of 10 mg/ ml. A total of 100 ml of each of the different lipids were added to a well in triplicate and left at RT overnight. The wells were blocked with 200 ml of blocking solution (2 mg/ ml of bovine serum albumin in PBS) for 1 h at 378C. After washing the wells three times with PBS, 100 ml of cell culture medium containing equal amounts of retinoschisin or MFGE8 were added and incubated at 48C overnight. The wells were then washed three times with PBS and bound protein was detected by ELISA using rabbit polyclonal antiretinoschisin or monoclonal anti-Rho (1D4) antibodies diluted 1:5000 in PBS and secondary anti-rabbit or anti-mouse IgG antibodies conjugated to horseradish peroxidase (Calbiochem). As a substrate, 100 ml of TMB (Sigma-Aldrich) was used and the absorbance was measured after addition of 10 ml of 37% HCl at 405 nm in a microtiter plate reader.
Binding to phospholipid vesicles
Uni-and oligolamellar phospholipid vesicles were prepared as described previously (45) . Briefly, 50 mg of lipids (PC, lipid mixture, 5:1 ratio of lipid mixture to PE or PS) was dissolved in diethyl ether and dried by rotary evaporation using Rotavapor R-3000 (Büchi Labortechnik GmbH, Essen, Germany). Lipids were then dissolved in 3 ml of diethyl ether, and 1 ml of PBS was added. The mixture was sonicated with a VibraCell VCX 400 sonifier (Sonics & Materials, Inc., Newtown, CT, USA) until a homogenous dispersion was formed. Diethyl ether was vaporized, and the lipids diluted with PBS were dialyzed against PBS, covered with argon and stored at 48C. To test protein binding to phospholipid vesicles, 50 mg of lipids was resolved in 300 ml of PBS and incubated with 300 ml of cell culture medium containing retinoschisin or MFGE8 for 30 min at RT. The mixtures were centrifuged at 48C and 16 000g for 15 min. Unbound protein in the supernatant was retained, and the pellet was washed in PBS at least once, centrifuged and resuspended in 300 ml of PBS. Equal volumes of vesicle and supernatant fractions were analyzed by western blotting.
Binding to membranes
Mouse tissues were homogenized in 200 ml of PBS supplemented with complete protease inhibitor (Roche Applied Sciences, Basel, Switzerland) using a TissueLyzer (QIAGEN). After removal of cell debris by centrifugation for 3 min at 2000g, total protein concentrations were determined by Bradford assay (Roti-quant w ). The homogenate was centrifuged at 16 000g for 20 min, the supernatant discarded and the pellet containing crude membranes (M) was washed once with 300 ml of PBS and spun at 16 000g for 20 min. The supernatant (W) was collected and the pellet was incubated in 300 ml of cell culture medium containing recombinant retinoschisin (input, I) for 20 min at 378C. Unbound protein was collected by centrifugation (16 000g, 20 min) and the pellet was washed four times with 300 ml of PBS. Aliquots were taken from all fractions and analyzed by western blotting. The binding assays were performed independently with membrane preparations from at least three mice.
Hek293-EBNA cells transfected with ATP1A3, ATP1B2, ATP1B2iso or empty pCEP4 vector were kept in Dulbecco's modified Eagle's medium 10% FCS for 2 days. The medium was then replaced with 5 ml of cell culture medium containing recombinant retinoschisin and incubated for 1 h at 378C. Cells were washed three times with PBS and scraped off in 1 ml of PBS. The cells were again washed three times with PBS and resuspended in 200 ml of PBS. Cells and wash fractions were analyzed by western blotting.
Immunofluorescence labeling
Enucleated mouse eyes were immersion-fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (PB [pH 7.4]) for 2 h. After rinsing several times in 0.1 M PB, the eyes were cryoprotected in 0.1 M PB containing 18% sucrose for 12 h, embedded in Tissue-Tek OCT and fast frozen in liquid nitrogen. Eyes were cryosectioned vertically at 10 mm. Cryosections were blocked with 0.1 M PB containing 0.3% Triton X-100 and 10% goat serum for 30 min and labeled overnight with primary antibodies diluted in 0.1 M PB, 0.1% Triton X-100 and 2.5% goat serum at RT. After washing in 0.1 M PB, the sections were incubated with secondary antibodies conjugated to Alexa 488 or Alexa 594 diluted 1:800 for 1 h and counterstained with 4 ′ ,6-diamidino-2-phenylindole (DAPI). Labeled sections were examined under an Axioskop-2 mot plus fluorescence microscope (Zeiss, Göttingen, Germany). Image processing was achieved with the Axiovision software with integrated Z-stack, 3D deconvolution and extended focus modules (Zeiss). Confocal microscopy was performed with the LSM 700 laser scanning microscope (Carl Zeiss, Jena).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
